Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein

por Asperen, J van, Tellingen, O van, Tijssen, F, Schinkel, A H, Beijnen, J H
Publicado 1999

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

por Tellingen, O van, Huizing, M T, Panday, V R Nannan, Schellens, J H M, Nooijen, W J, Beijnen, J H
Publicado 1999

Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study

por Doz, F, Gentet, J C, Pein, F, Frappaz, D, Chastagner, P, Moretti, S, Vassal, G, Arditti, J, Tellingen, O Van, Iliadis, A, Catalin, J
Publicado 2001

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

por Awada, A, Punt, C J A, Piccart, M J, Tellingen, O Van, Manen, L Van, Kerger, J, Groot, Y, Wanders, J, Verweij, J, Wagener, D J Th
Publicado 1999

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients

por Malingré, M M, Schellens, J H M, Tellingen, O Van, Ouwehand, M, Bardelmeijer, H A, Rosing, H, Koopman, F J, Schot, M E, Huinink, W W Ten Bokkel, Beijnen, J H
Publicado 2001